Edition:
United States

Acer Therapeutics Inc (ACER.OQ)

ACER.OQ on NASDAQ Stock Exchange Capital Market

11.81USD
15 Dec 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$11.81
Open
$11.78
Day's High
$12.00
Day's Low
$11.78
Volume
6,701
Avg. Vol
5,095
52-wk High
$21.71
52-wk Low
$5.70

Chart for

About

Acer Therapeutics Inc., formerly Opexa Therapeutics, Inc., is a pharmaceutical company. The Company is engaged in acquires, develops and intends to commercialize therapies for patients with serious rare diseases with critical unmet medical need. Its late-stage clinical pipeline includes Edsivo (celiprolol) and ACER-001. The... (more)

Overall

Beta: 2.24
Market Cap(Mil.): $76.18
Shares Outstanding(Mil.): 6.45
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 198.20 16.04
EPS (TTM): -- -- --
ROI: -- -11.76 34.69
ROE: -- -36.72 15.46

BRIEF-Acer Therapeutics Q3 loss per share $1.09

* Acer Therapeutics reports third quarter 2017 financial results and provides corporate update

Nov 13 2017

BRIEF-Acer Therapeutics welcomes two new members to its board

* Acer Therapeutics welcomes two new members to its board of directors

Oct 12 2017

Competitors

Earnings vs. Estimates